与埃文斯综合征相关的社区获得的Acinetobacter肺炎:一个病例报告
Sana Rasheed1, Huda Adnan1, Rida Arif1
1Department of Medicine and Surgery, Jinnah Sindh Medical University, Karachi, Pakistan.
Annals of medicine and surgery (2012)
|December 11, 2025
概括
在免疫功能低下的人群中,Acinetobacter baumannii会引起罕见的社区获得性肺炎 (CAP). 这一案例表明,在埃文斯综合征 (ES) 中,用多素和皮质类固醇成功治疗严重的CAP.
科学领域:
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 菌是社区获得性肺炎 (CAP) 的罕见原因,特别是在免疫功能低下的患者中.
- 埃文斯综合征 (ES) 是一种罕见的自身免疫性疾病,由于免疫反应的改变而使感染复杂化.
- 由于双重病理,在ES患者中管理CAP存在重大挑战.
研究的目的:
- 在患有埃文斯综合征的患者中报告一例由多药耐药的Acinetobacter baumannii引起的严重CAP病例.
- 突出诊断和治疗的挑战,在管理这些复杂的病例.
- 强调多学科方法的重要性.
主要方法:
- 一个19岁的男性患有ES和严重CAP的案例报告.
- 分析了临床表现,实验室发现和成像研究.
- 治疗包括针对多药耐药A. baumannii的抗生素和ES恶化的皮质类固醇.
主要成果:
- 患者出现了发烧,呼吸短促,生产性咳,血液溶解性贫血和血小板狭窄症.
- 最初的抗生素是无效的;polymyxin实现了感染控制.
- 感染加剧了患者的ES,需要双重治疗方法来稳定.
结论:
- Acinetobacter baumannii是CAP中新兴的病原体,特别是在免疫受损的宿主中.
- 及时诊断和有针对性的治疗,包括适当的抗生素和免疫抑制管理,至关重要.
- 传染病和免疫学专家之间的协作护理对于最佳结果至关重要.
相关概念视频
01:27Acute Pyelonephritis I: Introduction
436
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
436
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
285
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
285
01:21Acute Respiratory Failure-II
981
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
981
01:29Acute Respiratory Failure-V
421
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
421
01:21Acute Respiratory Failure-I
791
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
791
01:30Acute Respiratory Failure-III
728
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
728